Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1/2 7Phase 1 5Phase NA 3Phase EARLY_PHASE1 3Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 196Other solid neoplasm 6Tumor-Agnostic 5Gynecologic 5Head & Neck 2Gastrointestinal 2CNS 2Genitourinary 1

Conditions

Brain Neoplasms 2Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 64Temozolomide 59Vincristine 33Cyclophosphamide 32Carboplatin 30Radiosurgery 26Etoposide 25Cisplatin 25Lomustine 24Magnetic Resonance Spectroscopy 19Filgrastim 17Doxorubicin 15Bevacizumab 15Radiation 13Specimen Handling 12Granulocyte Colony-Stimulating Factor 12Surgical Procedures, Operative 11Isotretinoin 11Melphalan 10Carmustine 10Procarbazine 9Platinum 9Peripheral Blood Stem Cell Transplantation 9Chemotherapy, Adjuvant 9etoposide phosphate 7Topotecan 71,2-diaminocyclohexaneplatinum II citrate 7sargramostim 6Thiotepa 6Radiotherapy, Intensity-Modulated 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Pemetrexed × CNS × Clear all
NCT01951482 2025-08-17

Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung Cancer

Sun Yat-sen University

Phase 3 Completed
160 enrolled
CNS

Brain Neoplasms

NCT01951469 2022-03-08

Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer

Sun Yat-sen University

Phase 3 Unknown
160 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡